News

A new triple-drug treatment for aggressive advanced breast cancer can cut deaths by a third, a major trial has found.
A NEW triple threat drug combination could hold aggressive breast cancer at bay for an extra year, a trial found. Adding the ...
A new three-drug combination could help women with a common form of aggressive breast cancer live longer, research suggests.
AstraZeneca has unveiled positive trial results for a breast cancer drug that can stop mutating tumours before they start to grow, hoping it will be one of a portfolio of medicines that will propel it ...
Together with its principal academic partner, The Institute of Cancer Research (ICR), The Royal Marsden is designated as the ...
The Royal Horticultural Society has named a coral-pink rose "Catherine’s Rose" in honor of the Princess of Wales to raise ...
The NIHR-funded collaboration aims to improve cancer detection and diagnosis through advanced artificial intelligence models ...
STOCKHOLM, May 2, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is proud to announce that The Royal Marsden NHS Foundation Trust in the UK has treated its first patient using a new and ...
Almost 2,000 patients were waiting for routine treatment at the Royal Marsden Trust in March, new figures show. It comes as a health and social care think tank warned efforts to reduce patients' ...